Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer
✍ Scribed by Taru A. Koski; Heli J. Lehtonen; Kowan J. Jee; Shinsuke Ninomiya; Simon A. Joosse; Pia Vahteristo; Maija Kiuru; Auli Karhu; Heli Sammalkorpi; Sakari Vanharanta; Rainer Lehtonen; Henrik Edgren; Petra M. Nederlof; Marja Hietala; Kristiina Aittomäki; Riitta Herva; Sakari Knuutila; Lauri A. Aaltonen; Virpi Launonen
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 450 KB
- Volume
- 48
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a tumor predisposition syndrome with cutaneous and uterine leiomyomatosis as well as renal cell cancer (RCC) as its clinical manifestations. HLRCC is caused by heterozygous germline mutations in the fumarate hydratase (fumarase) gene. In this study, we used array comparative genomic hybridization to identify the specific copy number changes characterizing the HLRCC‐associated RCCs. The study material comprised formalin‐fixed paraffin‐embedded renal tumors obtained from Finnish patients with HLRCC. All 11 investigated tumors displayed the papillary type 2 histopathology typical for HLRCC renal tumors. The most frequent copy number changes detected in at least 3/11 (27%) of the tumors were gains in chromosomes 2, 7, and 17, and losses in 13q12.3‐q21.1, 14, 18, and X. These findings provide genetic evidence for a distinct copy number profile in HLRCC renal tumors compared with sporadic RCC tumors of the same histopathological subtype, and delineate chromosomal regions that associate with this very aggressive form of RCC. © 2009 Wiley‐Liss, Inc.